Related Experiment Videos

Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets

C Sweet1, F G Hayden, K J Jakeman

  • 1Microbial Molecular Genetics and Cell Biology Research Group, University of Birmingham, United Kingdom.

Insights

Rimantadine-resistance mutations in H3N2 influenza viruses did not alter virulence in ferrets. Emergent drug-resistant viruses maintain similar growth and virulence, suggesting no fitness cost.

Area of Science:

  • Virology
  • Infectious Diseases
  • Drug Resistance

Background:

  • Influenza H3N2 viruses can develop resistance to antiviral drugs like rimantadine.
  • Understanding the impact of resistance mutations on viral fitness is crucial for treatment strategies.

Purpose of the Study:

  • To investigate the influence of rimantadine-resistance mutations on the virulence of human H3N2 influenza viruses in a ferret model.
  • To compare the virulence of drug-resistant mutants with their sensitive wild-type counterparts.

Main Methods:

  • Generation of H3N2 influenza virus mutants with single amino acid substitutions in the M2 protein.
  • Assessment of viral virulence and growth characteristics in a ferret model.
  • Comparative analysis of drug-resistant and drug-sensitive virus pairs.

Main Results:

  • Rimantadine-resistant H3N2 virus mutants with single amino acid substitutions at positions 27, 30, and 31 in the M2 sequence showed similar virulence to their wild-type counterparts.
  • While some differences in virulence were observed between specific mutant-wild-type pairs, overall virulence was largely unaffected.
  • Emergence of rimantadine resistance during treatment did not compromise viral growth or virulence.

Conclusions:

  • Rimantadine-resistance mutations in H3N2 influenza viruses do not significantly impact viral virulence in ferrets.
  • Viruses that develop resistance during antiviral therapy retain their growth characteristics and virulence, indicating no significant fitness penalty.

Related Concept Videos